Evidence map›Paper›PMID 37577177›Full record

ArticleAddiction neuroscience2023

Advancing Biomarkers for Treatment of Smoking and Nicotine Dependence: An Overview.

Jonathan D Pollock, Kay Wanke, Wilson M Compton

Open access · goldAbstract read
In one paragraph

Article in Addiction neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Jonathan D PollockNational Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.
Kay WankeNIH Office of Disease Prevention, National Institutes of Health, Bethesda, Maryland.
Wilson M ComptonNational Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.
National Institute on Drug Abuse · USNational Institutes of Health · USOffice of Disease Prevention · US

Funding

Intramural NIH HHS Z99 DA999999
6 · The paper itself

Abstract

The special issue on Biomarkers of Nicotine and Tobacco Dependence reviews the science for precision treatment of nicotine dependence and future opportunities for research on biomarkers for inclusion in tobacco product cessation and switching clinical trials to advance translation. This overview summarizes the articles contributed to the special issue by leading researcher in field of addiction.

Indexed as

biomarkersnicotine addiction and dependencesmokingsmoking cessationtobacco

Identifiers

PMID37577177
PMCPMC10421606
OpenAlexW4383645718

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.